WOOJUNG BIO, Inc. (KOSDAQ:215380)
South Korea
· Delayed Price · Currency is KRW 1,473.00
-19.00 (-1.27%)
Mar 18, 2025, 9:00 AM KST
WOOJUNG BIO Revenue
In the year 2024, WOOJUNG BIO had annual revenue of 43.20B KRW with 11.87% growth. WOOJUNG BIO had revenue of 11.97B in the quarter ending December 31, 2024, a decrease of -33.16%.
Revenue
43.20B
Revenue Growth
+11.87%
P/S Ratio
0.51
Revenue / Employee
n/a
Employees
n/a
Market Cap
24.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 43.20B | 4.58B | 11.87% |
| Dec 31, 2023 | 38.62B | -8.30B | -17.70% |
| Dec 31, 2022 | 46.92B | 15.68B | 50.20% |
| Dec 31, 2021 | 31.24B | -6.11B | -16.35% |
| Dec 31, 2020 | 37.34B | 5.05B | 15.65% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |